EDGAR Filing Documents for 0001654954-17-005155

Form F-3/A - Registration statement by foreign private issuers: [Amend]

SEC Accession No. 0001654954-17-005155

Filing Date

2017-05-30

Accepted

2017-05-26 21:43:19

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO.1 TO REGISTRATION STATEMENT FOR FOREIGN ISSUERS	f-3a.htm	F-3/A	92937
2	OPINION OF GOWLING WLG (CANADA) LLP AS TO THE LEGALITY OF THE SECURITIES BEING R	exhibit_5-1.htm	EX-5.1	25327
3	TAX OPINION OF BLANK ROME LLP	exhibit_8-1.htm	EX-8.1	14777
4	TAX OPINION OF GOWLING WLG (CANADA) LLP	exhibit_8-2.htm	EX-8.2	12634
5	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (MNP LLP)	exhibit_23-1.htm	EX-23.1	5892
6	CONSENT OF DELOITTE LLP	exhibit_23-2.htm	EX-23.2	7420
7	IMAGE	intellipharmaceutics_logo.jpg	GRAPHIC	7239
8	IMAGE	mnp_address-1.jpg	GRAPHIC	5048
9	IMAGE	mnp_address-2.jpg	GRAPHIC	6286
10	IMAGE	mnp_logo.jpg	GRAPHIC	2454
	Complete submission text file	0001654954-17-005155.txt		189606

Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2

Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001

Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)